Journal of Criminal Law and Criminology Volume 72 Article 20 Issue 4 Winter

Winter 1981 An Appraisal of Human Experimentation in International Law and Practice: The eedN for International Regulation of Human Experimentation M. Cheriff aB ssiouni

Thomas G. Baffes

John T. Evrard

Follow this and additional works at: https://scholarlycommons.law.northwestern.edu/jclc Part of the Criminal Law Commons, Criminology Commons, and the Criminology and Criminal Justice Commons

Recommended Citation M. Cheriff asB siouni, Thomas G. Baffes, John T. Evrard, An Appraisal of Human Experimentation in International Law and Practice: The eN ed for International Regulation of Human Experimentation, 72 J. Crim. L. & Criminology 1597 (1981)

This Criminal Law is brought to you for free and open access by Northwestern University School of Law Scholarly Commons. It has been accepted for inclusion in Journal of Criminal Law and Criminology by an authorized editor of Northwestern University School of Law Scholarly Commons. 0091-4169/81/7204-1597 THEJOURNAL OF CRIMINAL LAW & CRIMINOLOGY Vol. 72, No. 4 Copyright © 1981 by Northwestern University School of Law rintedin USA.

AN APPRAISAL OF HUMAN EXPERIMENTATION IN INTERNATIONAL LAW AND PRACTICE: THE NEED FOR INTERNATIONAL REGULATION OF HUMAN EXPERIMENTATION

M. CHERIFF BASSIOUNI,* THOMAS G. BAFFES,** JOHN T. EVRARD***

I. INTRODUCTION Human experimentation can be broadly defined as anything done to an individual to learn how it will affect him.' Its main objective is the acquisition of new scientific knowledge rather than therapy. If an ex- periment is ultimately beneficial to others or even to the subject himself, this does not mean that therapy served an important purpose.2 There are three distinguishable types of cases involving the treatment of human subjects. The first is traditional treatment which uses normal and approved methods and techniques for therapeutic purposes. The second is research treatment, which means that a sick person is treated with new methods and techniques primarily for therapeutic purposes. This is sometimes called therapeutic experimentation. The third is re-

* Professor of Law, DePaul University College of Law; Secretary General, International Association of Penal Law, Paris; Dean, International Institute of Higher Studies in Criminal Sciences, Siracusa, Italy. S.J.D., George Washington Law Center, 1973; LL.M., John Mar- shall Law Institute, 1966; J.D., Indiana University, 1964. The article was written with the assistance of Thomas G. Baffes and John T. Evrard. ** Chairman, Dep't of Surgery Mount Sinai Hospital; Lecturer in Law, DePaul Univer- sity. LL.M. (1980), J.D. (1975), DePaul University College of Law; M.D., Tulane University Medical School, 1945; B.S., Tulane University, 1943. *** Assistant to Professor Bassiouni. J.D., DePaul University College of Law, 1980; M.A., University of Chicago, 1971; B.A., University of Illinois, 1970. 1 Bowker, Experiamenation on Humans and Gi)?r of Tissue: Artide 20-23 of the Civil Code, 19 McGILL L.J. 161, 164 (1973). 2 Id.

1597 1598 M. CHERIFBASSIOUN ET AL [Vol. 72 search which consists of treating individuals with new procedures and drugs for purely scientific purposes. This may be labelled "research experimentation. "3 If medical progress were to depend solely upon the scientific by- product of experimentation conducted incidental to therapy, medical science and human health care might, figuratively, still be in the dark ages. Throughout medical history, research experimentation has played a central role in the development of knowledge which is beneficial to human health. The influence of human experimentation permeates not only medicine and the other biological sciences but also behavioral, soci- ological, political, economic, and military endeavors. Because human experimentation deals with effects upon large numbers of people, experi- menters possess the potential to enhance or diminish the welfare of man- kind.4 Since this potential may result in willful, reckless or inadvertent acts harmful to human beings, human experimentation is also a proper concern for the international criminologist. Moreover, because of the focus upon individual conduct rather than state action, experimentation creates relatively neutral political concerns so that sovereign nations can meet without fear of retaliation or loss of power and reasonably expect to reach agreement on regulatory schemes. The prospects for success are important in our time, when international policy-makers find them- selves with inadequate measures to implement and enforce international laws.5 Since mutual agreement among sovereign nations is necessary to secure enforcement, the potential for international cooperation in human experimentation must be fully explored. In this manner ade- quate measures can be developed to protect human subjects from abuse.

II. HISTORICAL SURVEY OF HUMAN EXPERIMENTATION The history of human experimentation dates to some of the oldest writings on earth. The effects of innoculation were studied by the Chi- nese of the Sung Dynasty in 590 B.C. and were recorded in a Sanskrit text, studied in India in the second and third centuries A.D. 6 The prac-

3 Giesen, Civil Liability of Physiciansfor New Methods of Treatment and Experimentation, 25 INT'L & CoMP. L. Q. 180, 188 (1976). 4 See general4y L. CLENDENING, SOURCE BOOK OF MEDICAL HISTORY (1960); F. GARRI- SON, AN INTRODUCTION TO THE HISTORY OF MEDICINE (1913). 5 See Mueller & Besharov, The Existence of InternationalCriminal Law and Its Evolution to the Point of Its Enforcement Crisis, in 1 A TREATISE ON INTERNATIONAL CRIMINAL LAW 1 (M. C. Bassiouni & V. Nanda, ed. 1973) [hereinafter referred to as INTERNATIONAL CRIMINAL LAW]. There is increasing recognition of the need to expand and strengthen the international regula- tion of human experimentation by means of a convention in the form of existing human rights conventions. See Schwarzenberg, Pour an Code Internationalde Deontologie Medicale, Le Monde, June 14, 1979, at 8, col. 4. See notes 327-29 & accompanying text injfa. 6 Bollet, Smalox: The Biography of a Disease-I,RESIDENT AND STAFF PHYSICIAN, Aug. 1978, at 47, 48. 1981] HUMAN EXPERIMENTA TION APPRAISAL 1599

tice in ancient Persia was for the king to consign condemned criminals to scientific experimentation. The Ptolemies permitted this practice in Egypt, and it existed in Renaissance Pisa.7 When Hippocrates asserted that epilepsy is not an act of divine intervention but an ordinary disease, he set the stage for the study of neurology and mental disease.8 Galen stressed experimentation in conjunction with observation, formalizing medical experimentation in Western society about 1800 years ago. 9 Harvey's dominance in the seventeenth century supplanted the earlier dominance of Galen. In particular, Harvey carried out controlled ex- periments on animals and man in order to demonstrate that blood circu- lates through the heart and lungs.' 0 The number and diversity of experiments on human subjects has accelerated since the mid-eighteenth century. Some of the more note- worthy examples are: Lind's highly controlled study in 1757 demon- strating that citrus fruits cure scurvy; Jenner's publication in 1798 of experimental results showing the value of vaccination against smallpox; Davy's beautifully planned studies in 1799, giving rise to modern anes- thesia, which was followed, after much controversy, by Morton's first public demonstration of anesthesia in 1846; 11 Pasteur's discovery that inoculation with attenuated rabies virus induced immunity to bites from rabid animals; I2 and Korotkoff's studies in 1905 which measured arte- rial blood pressure. 13 The zeal to acquire new knowledge often prompted the experimenter to use himself as subject, sometimes with severe results. For example, in 1767 John Hunter inoculated himself with the pus of gonorrhea to prove that the disease is transmissable. He succeeded but also contracted syphilis from the inoculation. Walter Reed subjected himself to the effects of yellow fever virus in order to di